FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.3  |  FHIR Version n/a  User: [n/a]

1464701000168109: Nucala (mepolizumab 100 mg / 1 mL) injection, 1 mL pen device (trade product unit of use)

Status: current, Defined. Date: 31-May 2020. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
4389611000168116 Nucala (mepolizumab 100 mg / 1 mL) injection, 1 mL pen device (trade product unit of use) en Fully specified name Active Case sensitive Australian Medicines Terminology module
4389621000168111 Nucala 100 mg/mL injection, 1 mL pen device en Synonym Active Case sensitive Australian Medicines Terminology module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Nucala 100 mg/mL injection, 1 mL pen device Is a mepolizumab 100 mg/mL injection, pen device true Inferred relationship Some
Nucala 100 mg/mL injection, 1 mL pen device Is a trade product unit of use true Inferred relationship Some
Nucala 100 mg/mL injection, 1 mL pen device Is a Nucala true Inferred relationship Some
Nucala 100 mg/mL injection, 1 mL pen device has manufactured dose form injection true Inferred relationship Some
Nucala 100 mg/mL injection, 1 mL pen device has intended active ingredient mepolizumab true Inferred relationship Some 1988660660
Nucala 100 mg/mL injection, 1 mL pen device has Australian BoSS mepolizumab true Inferred relationship Some 1988660660
Nucala 100 mg/mL injection, 1 mL pen device has unit of use pen device true Inferred relationship Some 1212808610
Inbound Relationships Type Active Source Characteristic Refinability Group
Nucala 100 mg/mL injection, 1 mL pen device has TPUU True Nucala 100 mg/mL injection, 1 mL pen device Inferred relationship Some 662257581
Nucala 100 mg/mL injection, 1 mL pen device has TPUU True Nucala 100 mg/mL injection, 1 mL pen device Inferred relationship Some 1088430768

Reference Sets

Trade product unit of use reference set

Back to Start